RMTI · Rockwell Medical, Inc.
$7.31
+0.53 (+7.82%)
At close · Jul 27
Market Cap
$261.69M
Shares
39.47M
Rockwell Medical, Inc. Earnings Call Transcripts
Every quarterly earnings call for Rockwell Medical, Inc. (RMTI) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲26%
$19.31M
−$2.36M
'22 Q4
23-03-30
▲22%
$19.67M
−$1.75M
'23 Q1
23-05-15
▼3.2%
$18.08M
−$3.31M
'23 Q2
23-08-14
▲27.2%
$23.77M
−$1.87M
'23 Q3
23-11-14
▲14.4%
$22.09M
−$1.51M
'23 Q4
24-03-21
▲15.3%
$22.68M
−$1.73M
'24 Q1
24-05-14
▲42.9%
$25.83M
$343,000
'24 Q2
24-08-08
▲19.1%
$28.32M
$1.66M
'24 Q3
24-11-12
▲11.6%
$24.66M
−$756,000
'24 Q4
25-03-20
▼16.6%
$18.91M
−$1.51M
'25 Q1
25-05-12
▼37.8%
$16.07M
−$1.49M
'25 Q2
25-08-14
▼43.8%
$15.93M
−$1.75M
'25 Q3
25-11-12
▼25.6%
$18.35M
−$554,000
'25 Q4
26-01-20
▼25.6%
$18.35M
−$554,000
'25 Q4
26-03-26
LATEST
▼8.3%
$17.34M
−$1.60M
'26 Q1
26-05-07
Earnings call
FY26 · Q2
2026-08-13
Rockwell Medical Second Quarter 2026 Results Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Rockwell Medical, Inc. Q1 FY2026 Earnings Call
Confident tone
Financial performance and profitability
Pricing actions
Customer base and diversification
Revenue
$17.34M
▼ 8.3% YoY Diluted EPS
$-0.40
Gross margin
16.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-26
Rockwell Medical Fourth Quarter and Full-Year 2025 Results Call
Confident tone
2026 outlook and long-term growth targets
Competitive positioning vs. Nipro and Fresenius
Customer diversification and concentration risk reduction
Revenue
$18.35M*
▼ 25.6% YoY Gross margin
21.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q4
2026-01-20
Rockwell Medical, Inc. Q4 FY2025 Earnings Call
Confident tone
2026 outlook and long-term growth targets
Competitive positioning vs. Nipro and Fresenius
Customer diversification and concentration risk reduction
Revenue
$18.35M*
▼ 25.6% YoY Gross margin
21.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Rockwell Medical, Inc. Q3 FY2025 Earnings Call
Positive tone
largest customer transition
adjusted EBITDA profitability
cost restructuring and rightsizing
Revenue
$15.93M
▼ 43.8% YoY Diluted EPS
$-0.50
▼ 225% YoY Gross margin
14.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Rockwell Medical, Inc. Q2 FY2025 Earnings Call
Positive tone
2025 financial guidance
Customer transition and largest customer loss
Gross margin and operating efficiency
Revenue
$16.07M
▼ 37.8% YoY Diluted EPS
$-0.50
▼ 600% YoY Gross margin
15.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Rockwell Medical, Inc. Q1 FY2025 Earnings Call
Positive tone
Largest customer transition and contract negotiation
Financial guidance reiteration
Tariff exposure
Revenue
$18.91M
▼ 16.6% YoY Diluted EPS
$-0.40
Gross margin
16.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-20
Rockwell Medical, Inc. Q4 FY2024 Earnings Call
Revenue
$24.66M*
▲ 11.6% YoY Gross margin
14.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Rockwell Medical, Inc. Q3 FY2024 Earnings Call
Positive tone
Raised 2024 guidance
New agreements (Nipro, at-home partner, Aqua)
Largest customer volume decline in 2025
Revenue
$28.32M
▲ 19.1% YoY Diluted EPS
$0.40
Gross margin
22.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Rockwell Medical, Inc. Q2 FY2024 Earnings Call
Confident tone
Revenue Growth
Gross Margin Expansion
Profitability and Cash Flow
Revenue
$25.83M
▲ 42.9% YoY Diluted EPS
$0.10
Gross margin
17.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Rockwell Medical, Inc. Q1 FY2024 Earnings Call
Confident tone
Raised 2024 guidance
Pricing power and margin expansion
New and expanded customer agreements
Revenue
$22.68M
▲ 15.3% YoY Diluted EPS
$-0.60
Gross margin
13.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-21
Rockwell Medical, Inc. Q4 FY2023 Earnings Call
Confident tone
Revenue Growth and Guidance
Gross Margin Improvement
Evoqua Acquisition and Integration
Revenue
$22.09M*
▲ 14.4% YoY Gross margin
13.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-14
Rockwell Medical, Inc. Q3 FY2023 Earnings Call
Revenue
$23.77M
▲ 27.2% YoY Diluted EPS
$-0.70
Gross margin
9.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Rockwell Medical, Inc. Q2 FY2023 Earnings Call
Revenue
$18.08M
▼ 3.2% YoY Diluted EPS
$-1.80
Gross margin
5.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Rockwell Medical, Inc. Q1 FY2023 Earnings Call
Revenue
$19.67M
▲ 22% YoY Diluted EPS
$-1.00
Gross margin
13.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-30
Rockwell Medical, Inc. Q4 FY2022 Earnings Call
Revenue
$19.31M*
▲ 26% YoY Gross margin
12.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Rockwell Medical, Inc. Q3 FY2022 Earnings Call
Revenue
$18.69M
▲ 16.9% YoY Diluted EPS
$-2.30
Gross margin
4.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-15
Rockwell Medical, Inc. Q2 FY2022 Earnings Call
Revenue
$18.68M
▲ 23.4% YoY Diluted EPS
$-4.30
Gross margin
9.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-16
Rockwell Medical, Inc. Q1 FY2022 Earnings Call
Revenue
$16.12M
▲ 4.2% YoY Diluted EPS
$-8.40
Gross margin
-4.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q3
2021-11-15
Rockwell Medical, Inc. Q3 FY2021 Earnings Call
Revenue
$15.99M
▲ 4.6% YoY Diluted EPS
$-8.90
Gross margin
-2.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-16
Rockwell Medical, Inc. Q2 FY2021 Earnings Call
Revenue
$15.14M
▼ 4.8% YoY Diluted EPS
$-9.90
Gross margin
-1.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-17
Rockwell Medical, Inc. Q1 FY2021 Earnings Call
Revenue
$15.47M
▼ 2.4% YoY Diluted EPS
$-9.10
Gross margin
2.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-31
Rockwell Medical, Inc. Q4 FY2020 Earnings Call
Revenue
$15.16M*
▼ 2.1% YoY Gross margin
2.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Rockwell Medical, Inc. Q3 FY2020 Earnings Call
Revenue
$15.28M
▼ 0.8% YoY Diluted EPS
$-11.00
Gross margin
2.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Rockwell Medical, Inc. Q2 FY2020 Earnings Call
Revenue
$15.90M
▲ 7.1% YoY Diluted EPS
$-11.00
Gross margin
5.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
Rockwell Medical, Inc. Q1 FY2020 Earnings Call
Revenue
$15.86M
▲ 1.9% YoY Diluted EPS
$-13.20
Gross margin
7.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–26 of 26 earnings calls